Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
2425-C BENEFICIAL EFFECTS OF LUSEOGLIFLOZIN FOR HEPATIC STEATOSIS AND FIBROSIS INDEXES WITH A REDUCTION OF BODY WEIGHT AND AN INCREASE IN SERUM ALBUMIN LEVELS IN PATIENTS WITH DIABETES: A POOLED META-ANALYSIS OF PHASE III CLINICAL TRIALS USING INVERSE PROBABILITY TREATMENT WEIGHTING PROPENSITY ANALYSIS Takumi Kawaguchi 1,2 , Kenta Murotani 2,3 , Yoko Shirouzu 4 , Hitoshi Obara 3 , Hironori Yamaguchi 4 , Yuko Toyofuku 2 , Fumi Kaneko 2 and Saeko Uchida 4 , (1)Kurume University School of Medicine, (2)Kurume University Hospital, (3)Kurume University, (4)Taisho Pharmaceutical Co., Ltd
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification
Compared with the healthy control and NAFL groups, the NASH group had significantly increased proportions of HSCs and myofibroblasts, which were distributed in the lobule and the portal area around the fibrotic area
The metabolic support process develops progressively over weeks to months
US$ 21.64
US$ 29.37
US$ 23.97
